Literature DB >> 27927823

Secondary antibody deficiency - causes and approach to diagnosis.

Sapna Srivastava1, Philip Wood1.   

Abstract

Antibody deficiencies can occur in the context of primary disorders due to inherited genetic defects; however, secondary immune disorders are far more prevalent and can be caused by various diseases and their treatment, certain medications and surgical procedures. Immunoglobulin replacement therapy has been shown to be effective in reducing infections, morbidity and mortality in primary antibody deficiencies but secondary antibody deficiencies are in general poorly defined and there are no guidelines for the management of patients with this condition. Clinical decisions are based on experience from primary antibody deficiencies. Both primary and secondary antibody deficiencies can be associated with infections, immune dysregulation and end-organ damage, causing significant morbidity and mortality. Therefore, it is important to diagnose and treat these patients promptly to minimise adverse effects and improve quality of life. We focus on secondary antibody deficiency and describe the causes, diagnosis and treatment of this disorder. © Royal College of Physicians 2016. All rights reserved.

Entities:  

Keywords:  antibody deficiency; immunodeficiency; immunoglobulin replacement; malignancy; secondary hypogammaglobulinaemia

Mesh:

Substances:

Year:  2016        PMID: 27927823      PMCID: PMC6297325          DOI: 10.7861/clinmedicine.16-6-571

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  9 in total

1.  Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management.

Authors:  Silvia Sánchez-Ramón; Arancha Bermúdez; Luis Ignacio González-Granado; Carlos Rodríguez-Gallego; Ana Sastre; Pere Soler-Palacín
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

Review 2.  The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.

Authors:  Smita Y Patel; Javier Carbone; Stephen Jolles
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

3.  Iatrogenic antibody deficiency from B-cell targeted therapies in autoimmune rheumatic diseases.

Authors:  Sonali Wijetilleka; David Jayne; Chetan Mukhtyar; Mohammed Yousuf Karim
Journal:  Lupus Sci Med       Date:  2019-07-30

4.  Serum Protein Electrophoresis May Be Used as a Screening Tool for Antibody Deficiency in Children and Adolescents.

Authors:  Cristina Frias Sartorelli de Toledo Piza; Carolina Sanchez Aranda; Dirceu Solé; Stephen Jolles; Antonio Condino-Neto
Journal:  Front Immunol       Date:  2021-08-23       Impact factor: 7.561

5.  Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain.

Authors:  J Bruno Montoro; Pedro Moral Moral; Olaf Neth; Marta Ortiz Pica; Silvia Sánchez-Ramón; Laia Alsina; María Presa; Itziar Oyagüez; Miguel Ángel Casado; Luis Ignacio González-Granado
Journal:  Eur J Health Econ       Date:  2021-09-21

Review 6.  Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases.

Authors:  Mark Ballow; Silvia Sánchez-Ramón; Jolan E Walter
Journal:  Front Immunol       Date:  2022-07-18       Impact factor: 8.786

Review 7.  Primary immunodeficiency.

Authors:  Christine McCusker; Julia Upton; Richard Warrington
Journal:  Allergy Asthma Clin Immunol       Date:  2018-09-12       Impact factor: 3.406

8.  Secondary Immunodeficiency and Hypogammaglobulinemia with IgG Levels of <5 g/L in Patients with Multiple Myeloma: A Retrospective Study Between 2012 and 2020 at a University Hospital in China.

Authors:  Chunmei Ye; Weiwei Chen; Qi Gao; Yanxia Chen; Xiaolu Song; Sujie Zheng; Jinlin Liu
Journal:  Med Sci Monit       Date:  2021-07-09

Review 9.  Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data.

Authors:  Irina Kareva; Anup Zutshi; Cristina Vazquez Mateo; Orestis Papasouliotis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-07-30       Impact factor: 2.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.